These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

614 related articles for article (PubMed ID: 31959730)

  • 1. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
    O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
    Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte NLRP3 inflammasome and interleukin-1β activation modulated by alpha-1 antitrypsin therapy in deficient individuals.
    Gogoi D; Yu H; Casey M; Baird R; Yusuf A; Forde L; O' Brien ME; West JR; Flagg T; McElvaney NG; Eden E; Mueller C; Brantly ML; Geraghty P; Reeves EP
    Thorax; 2024 Aug; 79(9):822-833. PubMed ID: 38418195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.
    Chorostowska-Wynimko J; Barrecheguren M; Ferrarotti I; Greulich T; Sandhaus RA; Campos M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():345-355. PubMed ID: 32103933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
    Dummer J; Dobler CC; Holmes M; Chambers D; Yang IA; Parkin L; Smith S; Wark P; Dev A; Hodge S; Dabscheck E; Gooi J; Samuel S; Knowles S; Holland AE
    Respirology; 2020 Mar; 25(3):321-335. PubMed ID: 32030868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
    Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
    Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
    Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
    EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency.
    Fee LT; Gogoi D; O'Brien ME; McHugh E; Casey M; Gough C; Murphy M; Hopkins AM; Carroll TP; McElvaney NG; Reeves EP
    Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
    Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
    Franciosi AN; McCarthy C; McElvaney NG
    Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of Alpha-1 Antitrypsin Deficiency.
    Strange C; Beiko T
    Semin Respir Crit Care Med; 2015 Aug; 36(4):470-7. PubMed ID: 26238635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α
    Murphy MP; McEnery T; McQuillan K; McElvaney OF; McElvaney OJ; Landers S; Coleman O; Bussayajirapong A; Hawkins P; Henry M; Meleady P; Reeves EP; McElvaney NG
    Eur Respir J; 2020 Apr; 55(4):. PubMed ID: 32060059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
    Rahaghi FF; Miravitlles M
    Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic.
    Herth FJF; Sandhaus RA; Turner AM; Sucena M; Welte T; Greulich T
    Int J Chron Obstruct Pulmon Dis; 2021; 16():2983-2996. PubMed ID: 34754184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.
    McEnery T; White MM; Gogoi D; Coleman O; Bergin D; Jundi B; Flannery R; Alsaif FAT; Landers SA; Casey M; Dunlea D; Meleady P; McElvaney NG; Reeves EP
    Am J Respir Cell Mol Biol; 2022 Jul; 67(1):76-88. PubMed ID: 35507773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
    O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
    J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, Placebo-Controlled Trials in Alpha-1 Antitrypsin Deficiency.
    Sandhaus RA
    Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S370-3. PubMed ID: 27564674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
    Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
    Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of Alpha-1 Antitrypsin Lung Disease.
    Kalfopoulos M; Wetmore K; ElMallah MK
    Methods Mol Biol; 2017; 1639():9-19. PubMed ID: 28752442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha1-antitrypsin deficiency: forgotten etiology.
    Kaplan A; Cosentino L
    Can Fam Physician; 2010 Jan; 56(1):19-24. PubMed ID: 20090075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency.
    Everaerts S; Hartman JE; Van Dijk M; Koster TD; Slebos DJ; Klooster K
    Respiration; 2023; 102(2):134-142. PubMed ID: 36549279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.